A detailed history of Keynote Financial Services LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Keynote Financial Services LLC holds 1,775 shares of LLY stock, worth $1.33 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
1,775
Previous 2,016 11.95%
Holding current value
$1.33 Million
Previous $1.83 Billion 13.84%
% of portfolio
1.2%
Previous 1.53%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$772.14 - $960.02 $186,085 - $231,364
-241 Reduced 11.95%
1,775 $1.57 Billion
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.25%
2,016 $1.83 Billion
Q1 2024

Jun 13, 2024

BUY
$592.2 - $792.28 $1.19 Million - $1.59 Million
2,011 New
2,011 $1.56 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.